Kotak Securities suggests investing in Jubilant Ingrevia and Vishal Mega Mart due to their promising growth prospects. Vishal Mega Mart is poised for expansion, while Jubilant Ingrevia focuses on high-margin specialty chemicals to fuel future growth.

Jubilant Ingrevia has officially taken over Remidex Pharma, securing a full ownership position as per the deal announced on March 13, 2026. This acquisition is expected to strengthen Jubilant Ingrevia's pharmaceutical portfolio significantly.